254 filings
Page 6 of 13
8-K
mmihrb jzewvr
23 Dec 20
Genprex, Inc. Announces $12 Million
4:41pm
424B5
tdwyb966w90uy9zm
23 Dec 20
Prospectus supplement for primary offering
4:32pm
8-K
81wtfc7
16 Nov 20
Other Events
4:33pm
RW
3p7mck tjvz5
2 Oct 20
Registration withdrawal request
4:26pm
8-K
3am7d8agg6znwrqec2zg
29 Sep 20
Other Events
9:06am
8-K
rmgenmarg54th9ya1r4
27 Aug 20
Departure of Directors or Certain Officers
4:21pm
8-K
nhsuzqn
14 Aug 20
Departure of Directors or Certain Officers
8:39am
8-K
t64srch3
3 Aug 20
Other Events
8:33am
EFFECT
8tvn9ro md7gkpr5ry
20 Jul 20
Notice of effectiveness
12:15am
CORRESP
o7d fjzo9vcas11mc
15 Jul 20
Correspondence with SEC
12:00am
CORRESP
j39vewew u7cmy
1 Jul 20
Correspondence with SEC
12:00am
UPLOAD
ztxum01k 5k0n
29 Jun 20
Letter from SEC
12:00am
8-K
mzs1uzmb3o1zez0u
23 Jun 20
Submission of Matters to a Vote of Security Holders
4:32pm
8-K
5r1vrqb
16 Jun 20
Genprex Expands Manufacturing Program with Aldevron to Advance Oncoprex™ Clinical Development
8:20am
8-K
951ohy6hamm8u0ap
28 May 20
Genprex Announces Receipt of $2.5 Million in Cash from Recent Warrant Exercises
4:08pm
424B3
hwzazjc7
21 May 20
Prospectus supplement
7:49am